State Getting $7.5M Settlement From Opioid Addiction Treatment Producer
In 2016, Wisconsin joined an anti-trust lawsuit against Indivior, the maker of a drug used to treat opioid addiction called Suboxone.
![Pills by Tom Varco (Own work) [CC BY-SA 3.0 (http://creativecommons.org/licenses/by-sa/3.0)], via Wikimedia Commons.](https://urbanmilwaukee.com/wp-content/uploads/2016/11/1024px-Lexapro_pills.jpg)
Pills by Tom Varco (Own work) (CC BY-SA 3.0), via Wikimedia Commons.
In 2016, Wisconsin’s then-Attorney General Brad Schimel led 41 states and the District of Columbia in filing a federal lawsuit against Indivior, which makes Suboxone.
The anti-trust lawsuit claimed the pharmaceutical company used illegal means to try and preserve its drug monopoly, so it could stifle generic competition and inflate prices. It alleged the company switched the Suboxone market from tablets to a type of film that dissolves on the tongue, while at the same time it tried to destroy the market for tablets.
In all, the states are set to get $102.5 million total from the settlement agreement, which was announced Friday and still needs to be approved by a U.S. District Court judge in the Eastern District of Pennsylvania.
“We take our role as a responsible steward of medications for addiction and rescue extremely seriously,” Indivior’s CEO Mark Crossley said in a statement about the settlement. “Resolving these legacy matters at the right value allows us to further this mission for patients.”
As part of the settlement, Invidior agreed to notify the participating states about the introduction of new products, changes in corporate counsel or any citizen petitions to the U.S. Food and Drug Administration.
Those stipulations “will help the States ensure that Indivior refrains from engaging in the same kind of conduct alleged in the complaint,” according to a news release from the Wisconsin Department of Justice.
Suboxone is prescribed to prevent opioid overdose, reduce cravings and treat withdrawal symptoms.
For help with recovery from addiction, call the free and confidential treatment referral hotline (1-800-662- HELP), or visit findtreatment.gov.
Listen to the WPR report here.
Wisconsin poised to get $7.5M from lawsuit against maker of medication used to treat opioid abuse was originally published by Wisconsin Public Radio.
More about the Opioid Crisis
- MKE County: Drug Settlements Could Help Expand Opioid Addiction Programs - Graham Kilmer - Sep 21st, 2023
- DHS Awards Funding to Law Enforcement Agencies Working to Address the Opioid Epidemic - Wisconsin Department of Health Services - Sep 21st, 2023
- Milwaukee County Announces Locations of 11 ‘Harm Reduction Vending Machines’ to Combat Death from Overdose - County Executive David Crowley - Aug 8th, 2023
- Attorney General Kaul Joins Law Enforcement, Public Health Officials Across Wisconsin to Highlight Additional NARCAN® from Opioid Settlements - Wisconsin Department of Justice - Aug 8th, 2023
- Narcan Vending Machines Arrive in County - Isiah Holmes - Aug 8th, 2023
- DHS Announces Expansion of Harm Reduction Efforts - Wisconsin Department of Health Services - Jun 29th, 2023
- ‘They Die So Quickly’ From Fentanyl - Max Stapleton - Jun 26th, 2023
- Report Finds 1000% Increase in Fentanyl-Related Deaths - Isiah Holmes - Jun 13th, 2023
- Teva, Allergan, CVS, and Walgreens Finalize Opioid Settlement Agreements - Wisconsin Department of Justice - Jun 9th, 2023
- Current BOZA inconsistency and dysfunction detrimental to serving the public - Ald. Lamont Westmoreland - Jun 7th, 2023
Read more about Opioid Crisis here